1	LONDON	london	NNP	_	8	npadvmod	8:AM-DIS
2	-	-	:	p2=,	8	punct	_
3	The	the	DT	_	4	det	_
4	board	board	NN	_	8	nsubj	8:A0=PAG
5	of	of	IN	_	4	prep	_
6	AstraZeneca	astrazeneca	NNP	_	5	pobj	_
7	has	have	VBZ	_	8	aux	_
8	rejected	reject	VBN	pb=reject.01	0	root	_
9	the	the	DT	_	15	det	_
10	improved	improve	VBN	p2=JJ|pb=improve.01	15	amod	_
11	$	$	$	_	13	quantmod	_
12	119	0	CD	_	13	number	_
13	billion	#crd#	CD	_	15	nn	_
14	takeover	takeover	NN	p2=WDT	15	nn	_
15	offer	offer	NN	p2=VBP	8	dobj	8:A1=PPT;10:A1=PPT
16	from	from	IN	_	15	prep	_
17	U.S.	u.s.	NNP	_	19	nn	_
18	drugmaker	drugmaker	NN	p2=NNP	19	nn	_
19	Pfizer	pfizer	NNP	p2=NN	16	pobj	_
20	,	,	,	_	19	punct	_
21	a	a	DT	_	22	det	_
22	decision	decision	NN	_	19	appos	25:A0=CAU
23	that	that	WDT	_	25	nsubj	25:R-A0
24	has	have	VBZ	_	25	aux	_
25	caused	cause	VBN	pb=cause.01	22	rcmod	_
26	a	a	DT	_	28	det	_
27	sharp	sharp	JJ	_	28	amod	_
28	slide	slide	NN	_	25	dobj	25:A1=PPT
29	in	in	IN	_	28	prep	_
30	the	the	DT	_	32	det	_
31	U.K.	u.k.	NNP	_	32	nn	_
32	company	company	NN	_	35	poss	_
33	's	's	POS	_	32	possessive	_
34	share	share	NN	_	35	nn	_
35	price	price	NN	_	29	pobj	_
36	as	as	IN	_	39	mark	_
37	many	many	JJ	_	38	amod	_
38	investors	investor	NNS	_	39	nsubj	39:A0
39	think	think	VBP	pb=think.01	8	advcl	_
40	it	it	PRP	_	42	nsubj	42:A0=PAG
41	effectively	effectively	RB	_	42	advmod	42:AM-MNR
42	brings	bring	VBZ	pb=bring.01	39	ccomp	39:A1=PPT
43	an	an	DT	_	44	det	_
44	end	end	NN	_	42	dobj	42:A1=PPT
45	to	to	IN	_	44	prep	_
46	the	the	DT	_	52	det	_
47	protracted	protract	VBN	p2=JJ|pb=protract.01	52	amod	_
48	and	and	CC	_	47	cc	_
49	increasingly	increasingly	RB	_	50	advmod	_
50	bitter	bitter	JJ	_	47	conj	_
51	takeover	takeover	NN	_	52	nn	_
52	saga	saga	NN	_	45	pobj	47:A1=PPT
53	.	.	.	_	8	punct	_

1	Pfizer	pfizer	NNP	p2=NN	2	nn	_
2	Inc	inc	NNP	_	0	root	_
3	.	.	.	_	2	punct	_

1	,	,	,	_	3	punct	_
2	which	which	WDT	_	3	nsubj	3:R-A1
3	is	be	VBZ	pb=be.01	16	advcl	16:AM-DIS
4	the	the	DT	_	5	det	_
5	world	world	NN	_	10	poss	_
6	's	's	POS	_	5	possessive	_
7	second	#ord#	RB	_	9	hmod	_
8	-	-	HYPH	_	9	hyph	_
9	biggest	big	JJS	p2=RBS	10	amod	_
10	drugmaker	drugmaker	NN	_	3	attr	3:A2=PRD
11	by	by	IN	_	10	prep	_
12	revenue	revenue	NN	_	11	pobj	_
13	,	,	,	_	16	punct	_
14	has	have	VBZ	_	16	aux	_
15	been	be	VBN	_	16	aux	_
16	courting	court	VBG	pb=court.01	0	root	_
17	No.	no.	NN	p2=NNP	20	nn	_
18	8	0	CD	_	17	num	_
19	AstraZeneca	astrazeneca	NNP	_	20	nn	_
20	PLC	plc	NNP	_	16	dobj	16:A1=COM
21	since	since	IN	_	16	prep	16:AM-TMP
22	January	january	NNP	_	21	pobj	_
23	,	,	,	_	16	punct	_
24	arguing	argue	VBG	pb=argue.01	16	advcl	16:AM-ADV
25	that	that	IN	_	28	complm	_
26	their	their	PRP$	_	27	poss	_
27	businesses	business	NNS	_	28	nsubj	28:A1=PPT;32:A1=PPT
28	are	be	VBP	pb=be.01	24	ccomp	24:A1=PPT
29	complementary	complementary	JJ	_	28	acomp	28:A2=PRD
30	and	and	CC	_	28	cc	_
31	would	would	MD	_	32	aux	32:AM-MOD
32	be	be	VB	pb=be.01	28	conj	_
33	stronger	strong	JJR	p2=RBR	32	acomp	32:A2=PRD
34	together	together	RB	_	32	advmod	32:AM-MNR
35	.	.	.	_	16	punct	_

1	On	on	IN	_	5	prep	5:AM-TMP
2	Sunday	sunday	NNP	_	1	pobj	_
3	,	,	,	_	5	punct	_
4	it	it	PRP	_	5	nsubj	5:A0
5	said	say	VBD	pb=say.01	0	root	_
6	it	it	PRP	_	7	nsubj	10:A0=PAG;7:A1=PPT
7	was	be	VBD	pb=be.01	5	ccomp	5:A1=PPT
8	ready	ready	JJ	_	7	acomp	7:A2=PRD
9	to	to	TO	_	10	aux	_
10	raise	raise	VB	pb=raise.01	8	xcomp	_
11	its	its	PRP$	_	17	poss	_
12	stock	stock	NN	_	17	nn	_
13	-	-	HYPH	_	12	hyph	_
14	and	and	CC	_	12	cc	_
15	-	-	HYPH	_	16	hyph	_
16	cash	cash	NN	_	12	conj	_
17	offer	offer	NN	_	10	dobj	10:A1=PPT
18	by	by	IN	_	10	prep	10:AM-MNR
19	15	0	CD	_	20	num	_
20	percent	percent	NN	_	18	pobj	_
21	to	to	IN	_	10	prep	10:A4=GOL
22	$	$	$	_	24	quantmod	_
23	118.8	0	CD	_	24	number	_
24	billion	#crd#	CD	_	21	pobj	_
25	,	,	,	_	24	punct	_
26	or	or	CC	_	24	cc	_
27	70.73	0	CD	_	28	number	_
28	billion	#crd#	CD	_	29	num	_
29	pounds	pound	NNS	_	24	conj	_
30	.	.	.	_	5	punct	_

1	Because	because	IN	_	3	mark	_
2	Pfizer	pfizer	NNP	_	3	nsubj	3:A0
3	said	say	VBD	pb=say.01	30	advcl	_
4	it	it	PRP	_	7	nsubj	7:A0=PAG;12:A0=PAG
5	wo	wo	MD	_	7	aux	7:AM-MOD;12:AM-MOD
6	n't	not	RB	_	7	neg	7:AM-NEG;12:AM-NEG
7	raise	raise	VB	pb=raise.01	3	ccomp	3:A1=PPT
8	its	its	PRP$	_	9	poss	_
9	offer	offer	NN	_	7	dobj	7:A1=PPT
10	again	again	RB	_	7	advmod	7:AM-TMP
11	or	or	CC	_	7	cc	_
12	launch	launch	VB	pb=launch.01	7	conj	_
13	a	a	DT	_	16	det	_
14	hostile	hostile	JJ	_	16	amod	_
15	takeover	takeover	NN	_	16	nn	_
16	bid	bid	NN	p2=VBN	12	dobj	12:A1=PPT
17	over	over	IN	_	16	prep	_
18	the	the	DT	_	19	det	_
19	heads	head	NNS	_	17	pobj	_
20	of	of	IN	_	19	prep	_
21	AstraZeneca	astrazeneca	NNP	_	23	poss	_
22	's	's	POS	_	21	possessive	_
23	board	board	NN	_	20	pobj	_
24	,	,	,	_	30	punct	_
25	the	the	DT	_	26	det	_
26	prospect	prospect	NN	_	30	nsubj	30:A0=PAG
27	of	of	IN	_	26	prep	_
28	a	a	DT	_	29	det	_
29	deal	deal	NN	_	27	pobj	_
30	looks	look	VBZ	pb=look.02	0	root	_
31	increasingly	increasingly	RB	_	32	advmod	_
32	remote	remote	JJ	_	30	acomp	30:A1=PPT
33	unless	unless	IN	_	36	mark	_
34	AstraZeneca	astrazeneca	NNP	_	35	nn	_
35	shareholders	shareholder	NNS	_	36	nsubj	36:A0=PAG
36	urge	urge	VBP	pb=urge.01	30	advcl	30:AM-ADV
37	a	a	DT	_	38	det	_
38	change	change	NN	_	36	dobj	36:A1=PPT
39	of	of	IN	_	38	prep	_
40	mind	mind	NN	_	39	pobj	_
41	.	.	.	_	30	punct	_

1	Pfizer	pfizer	NNP	_	3	nsubj	3:A0
2	has	have	VBZ	_	3	aux	_
3	said	say	VBN	p2=VBD|pb=say.01	0	root	_
4	it	it	PRP	_	5	nsubj	5:A0
5	hopes	hope	VBZ	pb=hope.01	3	ccomp	3:A1=PPT
6	AstraZeneca	astrazeneca	NNP	_	8	poss	_
7	's	's	POS	_	6	possessive	_
8	shareholders	shareholder	NNS	_	10	nsubj	10:A0=PAG
9	will	will	MD	_	10	aux	10:AM-MOD
10	push	push	VB	pb=push.02	5	ccomp	5:A1=PPT
11	for	for	IN	_	10	prep	10:A2=PRD
12	a	a	DT	_	13	det	_
13	deal	deal	NN	_	11	pobj	_
14	.	.	.	_	3	punct	_

1	Shareholders	shareholder	NNS	_	5	nsubj	5:A0
2	in	in	IN	_	1	prep	_
3	AstraZeneca	astrazeneca	NNP	_	2	pobj	_
4	certainly	certainly	RB	_	5	advmod	5:AM-ADV
5	think	think	VBP	pb=think.01	0	root	_
6	a	a	DT	_	7	det	_
7	deal	deal	NN	_	8	nsubj	8:A1=PPT
8	is	be	VBZ	pb=be.01	5	ccomp	5:A1=PPT
9	now	now	RB	_	8	advmod	8:AM-TMP
10	unlikely	unlikely	JJ	p2=RB	8	acomp	8:A2=PRD
11	and	and	CC	_	8	cc	_
12	the	the	DT	_	13	det	_
13	company	company	NN	_	16	poss	_
14	's	's	POS	_	13	possessive	_
15	share	share	NN	_	16	nn	_
16	price	price	NN	_	17	nsubj	17:A1
17	slumped	slump	VBD	pb=slump.01	8	conj	_
18	14.7	0	CD	_	19	num	_
19	percent	percent	NN	_	17	dobj	_
20	to	to	IN	_	17	prep	17:A4=GOL
21	41.15	0	CD	_	22	num	_
22	pounds	pound	NNS	_	20	pobj	_
23	.	.	.	_	17	punct	_

1	Johansson	johansson	NNP	_	2	nsubj	2:A0
2	said	say	VBD	pb=say.01	0	root	_
3	in	in	IN	_	2	prep	2:AM-LOC
4	the	the	DT	_	6	det	_
5	rejection	rejection	NN	_	6	nn	_
6	statement	statement	NN	_	3	pobj	_
7	that	that	IN	p2=WDT	12	complm	_
8	his	his	PRP$	_	10	poss	_
9	management	management	NN	_	10	nn	_
10	team	team	NN	_	12	nsubj	12:A0=PAG
11	had	have	VBD	_	12	aux	_
12	told	tell	VBN	p2=VBD|pb=tell.01	2	ccomp	2:A1=PPT
13	Pfizer	pfizer	NNP	_	12	dobj	12:A2=GOL
14	over	over	IN	_	12	prep	12:AM-TMP
15	the	the	DT	_	16	det	_
16	weekend	weekend	NN	_	14	pobj	_
17	that	that	IN	_	20	complm	_
18	it	it	PRP	_	20	nsubj	20:A0=PAG;22:A0
19	would	would	MD	_	20	aux	20:AM-MOD
20	need	need	VB	pb=need.01	12	ccomp	12:A1=PPT
21	to	to	TO	_	22	aux	_
22	see	see	VB	pb=see.01	20	xcomp	20:A1=PPT
23	a	a	DT	_	26	det	_
24	10	0	CD	_	25	num	_
25	percent	percent	NN	_	26	nn	_
26	improvement	improvement	NN	_	22	dobj	22:A1
27	over	over	IN	_	26	prep	_
28	the	the	DT	_	35	det	_
29	53.50	0	CD	_	30	num	_
30	pounds	pound	NNS	_	34	hmod	_
31	-	-	HYPH	_	34	hyph	_
32	per	per	IN	_	34	hmod	_
33	-	-	HYPH	_	34	hyph	_
34	share	share	NN	_	35	nn	_
35	offer	offer	NN	_	27	pobj	37:A1=PPT
36	that	that	WDT	_	37	nsubj	37:R-A1
37	was	be	VBD	pb=be.01	35	rcmod	_
38	on	on	IN	_	37	prep	37:A2=PRD
39	the	the	DT	_	40	det	_
40	table	table	NN	_	38	pobj	_
41	at	at	IN	_	37	prep	37:AM-TMP
42	that	that	DT	_	43	det	_
43	time	time	NN	_	41	pobj	_
44	.	.	.	_	2	punct	_

1	He	he	PRP	_	2	nsubj	2:A0
2	said	say	VBD	pb=say.01	0	root	_
3	Pfizer	pfizer	NNP	_	6	poss	_
4	's	's	POS	_	3	possessive	_
5	latest	late	JJS	_	6	amod	_
6	offer	offer	NN	p2=VBP	7	nsubj	7:A0
7	represented	represented	VBD	pb=represent.01	2	ccomp	2:A1=PPT
8	only	only	RB	_	12	advmod	_
9	a	a	DT	_	12	det	_
10	"	"	``	_	12	punct	_
11	minor	minor	JJ	_	12	amod	_
12	improvement	improvement	NN	_	7	dobj	7:A1;15:A1=PPT
13	"	"	''	_	12	punct	_
14	that	that	WDT	_	15	nsubj	15:R-A1
15	fell	fall	VBD	pb=fall.01	12	rcmod	_
16	short	short	RB	p2=JJ	15	advmod	15:A4=GOL
17	of	of	IN	_	16	prep	_
18	the	the	DT	_	20	det	_
19	10	0	CD	_	20	num	_
20	percent	percent	NN	_	17	pobj	21:A1=PPT
21	needed	need	VBN	p2=VBD|pb=need.01	20	partmod	_
22	.	.	.	_	2	punct	_

1	Though	though	IN	_	4	mark	_
2	it	it	PRP	_	4	nsubj	4:A0
3	has	have	VBZ	_	4	aux	_
4	said	say	VBN	pb=say.01	0	root	_
5	its	its	PRP$	_	7	poss	_
6	indicative	indicative	JJ	_	7	amod	_
7	offer	offer	NN	_	8	nsubj	8:A1=PPT
8	is	be	VBZ	pb=be.01	4	ccomp	4:A1=PPT
9	final	final	JJ	_	8	acomp	8:A2=PRD
10	,	,	,	_	12	punct	_
11	Pfizer	pfizer	NNP	_	12	nsubj	12:A0=PAG
12	has	have	VBZ	pb=have.03	3	parataxis	_
13	,	,	,	_	12	punct	_
14	under	under	IN	_	12	prep	_
15	U.K.	u.k.	NNP	_	17	nn	_
16	takeover	takeover	NN	_	17	nn	_
17	rules	rule	NNS	_	14	pobj	_
18	,	,	,	_	12	punct	_
19	up	up	RB	p2=IN	12	advmod	_
20	until	until	IN	_	19	prep	_
21	5	0	CD	_	22	num	_
22	p.m.	p.m.	NN	p2=RB	8	attr	_
23	local	local	JJ	_	24	amod	_
24	time	time	NN	_	22	appos	_
25	May	may	NNP	p2=MD	28	nsubj	_
26	26	0	CD	_	25	num	_
27	to	to	TO	_	28	aux	_
28	make	make	VB	pb=make.LV	24	infmod	_
29	a	a	DT	_	31	det	_
30	formal	formal	JJ	_	31	amod	_
31	bid	bid	NN	_	28	dobj	28:AM-PRR
32	.	.	.	_	4	punct	_

1	If	if	IN	_	3	mark	_
2	it	it	PRP	_	3	nsubj	3:A0=PAG
3	does	do	VBZ	pb=do.02	9	advcl	9:AM-ADV
4	n't	not	RB	_	3	neg	3:AM-NEG
5	,	,	,	_	9	punct	_
6	it	it	PRP	_	9	nsubj	9:A0
7	can	can	MD	_	9	aux	9:AM-MOD
8	not	not	RB	_	9	neg	9:AM-NEG
9	make	make	VB	pb=make.LV	0	root	_
10	another	another	DT	_	11	det	_
11	offer	offer	NN	_	9	dobj	9:AM-PRR
12	for	for	IN	_	9	prep	9:AM-TMP
13	six	#crd#	CD	_	14	num	_
14	months	month	NNS	_	12	pobj	_
15	.	.	.	_	9	punct	_

1	For	for	IN	_	6	prep	6:AM-TMP
2	weeks	week	NNS	_	1	pobj	_
3	,	,	,	_	6	punct	_
4	Pfizer	pfizer	NNP	_	6	nsubj	6:A0=PAG;8:A0=PAG
5	has	have	VBZ	_	6	aux	_
6	sought	seek	VBN	pb=seek.01	0	root	_
7	to	to	TO	_	8	aux	_
8	get	get	VB	pb=get.01	6	xcomp	6:A1=PPT
9	the	the	DT	_	10	det	_
10	board	board	NN	_	12	poss	_
11	's	's	POS	_	10	possessive	_
12	approval	approval	NN	_	8	dobj	8:A1=PPT
13	for	for	IN	_	12	prep	_
14	what	what	WP	_	17	nsubj	17:R-A1
15	would	would	MD	_	17	aux	17:AM-MOD
16	have	have	VB	_	17	aux	_
17	been	be	VBN	pb=be.01	13	pcomp	_
18	the	the	DT	_	20	det	_
19	richest	rich	JJS	_	20	amod	_
20	acquisition	acquisition	NN	_	17	attr	17:A2=PRD
21	ever	ever	RB	_	20	advmod	_
22	among	among	IN	_	20	prep	_
23	drugmakers	drugmaker	NNS	_	22	pobj	_
24	and	and	CC	_	20	cc	_
25	the	the	DT	_	29	det	_
26	third	#ord#	RB	_	28	hmod	_
27	-	-	HYPH	_	28	hyph	_
28	biggest	big	JJS	_	29	amod	_
29	deal	deal	NN	_	20	conj	_
30	in	in	IN	_	29	prep	_
31	any	any	DT	_	32	det	_
32	industry	industry	NN	_	30	pobj	_
33	,	,	,	_	6	punct	_
34	according	accord	VBG	_	6	prep	_
35	to	to	IN	_	34	prep	_
36	figures	figure	NNS	_	35	pobj	_
37	from	from	IN	_	36	prep	_
38	research	research	NN	_	39	nn	_
39	firm	firm	NN	p2=JJ	40	nn	_
40	Dealogic	dealogic	NNP	_	37	pobj	_
41	.	.	.	_	6	punct	_

1	It	it	PRP	_	3	nsubj	3:A1=PPT
2	would	would	MD	_	3	aux	3:AM-MOD
3	be	be	VB	pb=be.01	0	root	_
4	Pfizer	pfizer	NNP	_	7	poss	_
5	's	's	POS	_	4	possessive	_
6	fourth	#ord#	JJ	_	7	amod	_
7	deal	deal	NN	_	3	attr	3:A2=PRD
8	worth	worth	JJ	p2=NN	7	amod	_
9	$	$	$	_	11	quantmod	_
10	60	0	CD	_	11	number	_
11	billion	#crd#	CD	_	8	npadvmod	_
12	or	or	CC	_	11	cc	_
13	more	more	JJR	_	11	conj	_
14	since	since	IN	_	7	prep	_
15	2000	0	CD	_	14	pobj	_
16	.	.	.	_	3	punct	_

1	Pfizer	pfizer	NNP	p2=NN	3	poss	_
2	's	's	POS	_	1	possessive	_
3	offer	offer	NN	_	4	nsubj	4:A1=PPT
4	comes	come	VBZ	pb=come.01	0	root	_
5	amid	amid	IN	_	4	prep	4:AM-TMP
6	a	a	DT	_	7	det	_
7	surge	surge	NN	_	5	pobj	_
8	of	of	IN	_	7	prep	_
9	other	other	JJ	_	10	amod	_
10	deals	deal	NNS	_	8	pobj	_
11	as	as	IN	p2=RB	13	mark	_
12	drugmakers	drugmaker	NNS	_	13	nsubj	13:A0=PPT
13	look	look	VBP	pb=look.01	4	advcl	4:AM-TMP
14	to	to	IN	p2=TO	13	prep	13:A1=GOL
15	either	either	CC	p2=DT	16	preconj	_
16	grow	grow	VB	p2=VBP	14	pobj	_
17	or	or	CC	_	16	cc	_
18	eliminate	eliminate	VB	pb=eliminate.01	16	conj	_
19	noncore	noncore	JJ	p2=NN	20	amod	_
20	assets	asset	NNS	_	18	dobj	18:A1=PPT
21	to	to	TO	_	22	aux	_
22	focus	focus	VB	pb=focus.01	18	advcl	_
23	on	on	IN	_	22	prep	22:A2=PPT
24	their	their	PRP$	_	25	poss	_
25	strengths	strength	NNS	_	23	pobj	_
26	.	.	.	_	4	punct	_

1	Those	those	DT	_	2	det	_
2	deals	deal	NNS	_	3	nsubj	3:A2=GOL
3	include	include	VBP	pb=include.01	0	root	_
4	Switzerland	switzerland	NNP	_	7	poss	_
5	's	's	POS	_	4	possessive	_
6	Novartis	novartis	NNP	_	7	nn	_
7	AG	ag	NNP	_	3	dobj	8:A0=PAG;10:A0=PAG;3:A1=PPT
8	agreeing	agree	VBG	pb=agree.01	7	partmod	_
9	to	to	TO	_	10	aux	_
10	buy	buy	VB	pb=buy.01	8	xcomp	8:A1=PPT
11	GlaxoSmithKline	glaxosmithkline	NNP	_	16	poss	_
12	's	's	POS	_	11	possessive	_
13	cancer	cancer	NN	_	15	hmod	_
14	-	-	HYPH	_	15	hyph	_
15	drug	drug	NN	_	16	nn	_
16	business	business	NN	_	10	dobj	10:A1=PPT
17	for	for	IN	_	10	prep	10:A3=VSP
18	up	up	IN	_	22	quantmod	_
19	to	to	TO	_	22	quantmod	_
20	$	$	$	_	22	quantmod	_
21	16	0	CD	_	22	number	_
22	billion	#crd#	CD	_	17	pobj	_
23	,	,	,	_	7	punct	_
24	to	to	TO	_	25	aux	_
25	sell	sell	VB	pb=sell.01	7	infmod	_
26	most	most	JJS	_	25	dobj	25:A1=PPT
27	of	of	IN	_	26	prep	_
28	its	its	PRP$	_	30	poss	_
29	vaccines	vaccine	NNS	_	30	nn	_
30	business	business	NN	_	27	pobj	_
31	to	to	TO	p2=IN	32	aux	_
32	GSK	gsk	VB	p2=NNP|pb=gsk.01	25	advcl	_
33	for	for	IN	_	32	prep	32:A3
34	$	$	$	_	36	quantmod	_
35	7.1	0	CD	_	36	number	_
36	billion	#crd#	CD	_	33	pobj	_
37	,	,	,	_	7	punct	_
38	plus	plus	CC	_	7	cc	_
39	royalties	royalty	NNS	_	7	conj	_
40	,	,	,	_	3	punct	_
41	and	and	CC	_	3	cc	_
42	to	to	TO	_	43	aux	_
43	sell	sell	VB	pb=sell.01	3	advcl	_
44	its	its	PRP$	_	47	poss	_
45	animal	animal	NN	p2=JJ	47	nn	_
46	health	health	NN	_	47	nn	_
47	division	division	NN	_	43	dobj	43:A1=PPT
48	to	to	IN	_	43	prep	43:A2=GOL
49	Eli	eli	NNP	_	50	nn	_
50	Lilly	lilly	NNP	_	48	pobj	_
51	and	and	CC	_	50	cc	_
52	Co.	co.	NNP	_	50	conj	_
53	of	of	IN	_	50	prep	_
54	Indianapolis	indianapolis	NNP	_	53	pobj	_
55	for	for	IN	_	43	prep	43:A3=VSP
56	about	about	RB	p2=IN	59	advmod	_
57	$	$	$	_	59	quantmod	_
58	5.4	0	CD	_	59	number	_
59	billion	#crd#	CD	_	55	pobj	_
60	.	.	.	_	3	punct	_

1	Canada	canada	NNP	_	4	poss	_
2	's	's	POS	p2=VBZ	1	possessive	_
3	Valeant	valeant	NNP	_	4	nn	_
4	Pharmaceuticals	pharmaceutical	NNPS	p2=NNP	7	nsubj	7:A0
5	has	have	VBZ	_	7	aux	_
6	also	also	RB	_	7	advmod	7:AM-ADV
7	made	make	VBN	pb=make.LV	0	root	_
8	an	an	DT	_	10	det	_
9	unsolicited	unsolicited	JJ	_	10	amod	_
10	offer	offer	NN	_	7	dobj	7:AM-PRR
11	of	of	IN	_	10	prep	_
12	nearly	nearly	RB	_	15	advmod	_
13	$	$	$	_	15	quantmod	_
14	46	0	CD	_	15	number	_
15	billion	#crd#	CD	_	11	pobj	_
16	for	for	IN	_	10	prep	_
17	Botox	botox	NNP	p2=NN	18	nn	_
18	maker	maker	NN	_	19	nn	_
19	Allergan	allergan	NNP	_	16	pobj	23:A0
20	,	,	,	_	19	punct	_
21	which	which	WDT	_	23	nsubj	23:R-A0
22	has	have	VBZ	_	23	aux	_
23	turned	turn	VBN	pb=turn.05	19	rcmod	_
24	it	it	PRP	_	23	dobj	23:A1=PPT
25	down	down	RP	_	23	prt	23:C-V
26	,	,	,	_	19	punct	_
27	so	so	RB	_	28	advmod	_
28	far	far	RB	_	23	advmod	23:AM-TMP
29	.	.	.	_	7	punct	_

1	While	while	IN	_	5	mark	_
2	Pfizer	pfizer	NNP	_	5	nsubjpass	_
3	is	be	VBZ	_	5	auxpass	_
4	best	well	RBS	p2=RB	5	advmod	_
5	known	known	JJ	p2=VBN	27	advcl	27:AM-ADV
6	to	to	IN	_	5	prep	_
7	the	the	DT	_	8	det	_
8	public	public	NN	p2=JJ	6	pobj	_
9	for	for	IN	_	5	prep	_
10	Viagra	viagra	NNP	p2=NN	9	pobj	_
11	,	,	,	_	10	punct	_
12	cholesterol	cholesterol	NN	_	13	nn	_
13	fighter	fighter	NN	_	14	nn	_
14	Lipitor	lipitor	NNP	p2=NN	37	nn	_
15	and	and	CC	_	14	cc	_
16	other	other	JJ	_	19	amod	_
17	widely	widely	RB	_	18	advmod	18:AM-EXT
18	used	use	VBN	p2=JJ|pb=use.01	19	amod	_
19	medicines	medicine	NNS	_	14	conj	18:A1=PPT
20	,	,	,	_	19	punct	_
21	in	in	IN	_	27	prep	27:AM-LOC
22	the	the	DT	_	24	det	_
23	pharmaceutical	pharmaceutical	JJ	p2=NN	24	amod	_
24	industry	industry	NN	_	21	pobj	_
25	it	it	PRP	_	27	nsubjpass	27:A1=PPT
26	's	's	VBZ	_	27	auxpass	_
27	known	know	VBN	p2=JJ|pb=know.01	0	root	_
28	for	for	IN	_	27	prep	27:A2=PRD
29	two	#crd#	CD	_	31	num	_
30	other	other	JJ	_	31	amod	_
31	things	thing	NNS	_	28	pobj	43:A0
32	:	:	:	_	31	punct	_
33	marketing	marketing	NN	p2=VBG	34	nn	_
34	muscle	muscle	NN	_	31	appos	_
35	and	and	CC	_	34	cc	_
36	mega	mega	JJ	p2=NN	37	amod	_
37	mergers	merger	NNS	_	34	conj	_
38	,	,	,	_	37	punct	_
39	which	which	WDT	_	43	nsubj	43:R-A0
40	together	together	RB	_	43	advmod	43:AM-MNR
41	have	have	VBP	_	43	aux	_
42	repeatedly	repeatedly	RB	_	43	advmod	43:AM-MNR
43	propelled	propel	VBN	pb=propel.01	31	rcmod	_
44	it	it	PRP	_	43	dobj	43:A1=PPT
45	to	to	IN	_	43	prep	43:A2=GOL
46	the	the	DT	_	47	det	_
47	top	top	NN	_	45	pobj	_
48	.	.	.	_	27	punct	_

1	Since	since	IN	_	6	prep	6:AM-TMP
2	2000	0	CD	_	1	pobj	_
3	,	,	,	_	6	punct	_
4	it	it	PRP	_	6	nsubjpass	6:A0=PAG
5	's	's	VBZ	_	6	auxpass	_
6	done	do	VBN	pb=do.02	0	root	_
7	three	#crd#	CD	_	8	num	_
8	acquisitions	acquisition	NNS	_	6	dobj	11:A0=PAG;6:A1=PPT
9	that	that	WDT	_	11	nsubj	11:R-A0;15:R-A0
10	have	have	VBP	_	11	aux	_
11	vaulted	vault	VBN	pb=vault.01	8	rcmod	_
12	the	the	DT	_	13	det	_
13	company	company	NN	_	11	dobj	15:A0;11:A1=PPT
14	to	to	TO	p2=IN	15	aux	_
15	No.	no.	VB	p2=$|pb=no..01	11	advcl	11:A3=DIR
16	1	0	CD	_	15	dobj	15:A1
17	in	in	IN	_	15	prep	_
18	revenue	revenue	NN	_	17	pobj	_
19	.	.	.	_	6	punct	_

1	It	it	PRP	_	2	nsubj	2:A0=PAG
2	paid	pay	VBD	pb=pay.01	0	root	_
3	$	$	$	_	5	quantmod	_
4	111.8	0	CD	_	5	number	_
5	billion	#crd#	CD	_	2	dobj	2:A1=VSP
6	for	for	IN	_	2	prep	2:A3=PPT
7	Warner	warner	NNP	_	9	hmod	_
8	-	-	HYPH	_	9	hyph	_
9	Lambert	lambert	NNP	_	10	nn	_
10	Co.	co.	NNP	_	6	pobj	_
11	in	in	IN	_	2	prep	2:AM-TMP
12	2000	0	CD	_	11	pobj	_
13	to	to	TO	_	14	aux	_
14	get	get	VB	pb=get.01	2	advcl	_
15	the	the	DT	_	16	det	_
16	rights	right	NNS	_	14	dobj	14:A1=PPT
17	to	to	IN	_	16	prep	_
18	Lipitor	lipitor	NNP	p2=NN	17	pobj	_
19	,	,	,	_	18	punct	_
20	then	then	RB	_	23	advmod	_
21	$	$	$	_	23	quantmod	_
22	59.8	0	CD	_	23	number	_
23	billion	#crd#	CD	_	18	appos	_
24	for	for	IN	_	23	prep	_
25	Pharmacia	pharmacia	NNP	_	26	nn	_
26	Corp	corp	NNP	_	24	pobj	_
27	.	.	.	_	2	punct	_

1	in	in	IN	p2=RP	6	prep	_
2	2003	0	CD	_	1	pobj	_
3	and	and	CC	_	2	cc	_
4	$	$	$	_	6	quantmod	_
5	68	0	CD	_	6	number	_
6	billion	#crd#	CD	_	0	root	_
7	for	for	IN	_	6	prep	_
8	Wyeth	wyeth	NNP	_	7	pobj	_
9	in	in	IN	_	6	prep	_
10	2009	0	CD	_	9	pobj	_
11	,	,	,	_	6	punct	_
12	according	accord	VBG	_	6	prep	_
13	to	to	IN	_	12	prep	_
14	Dealogic	dealogic	NNP	_	13	pobj	_
15	.	.	.	_	1	punct	_

1	With	with	IN	_	8	prep	8:AM-ADV
2	this	this	DT	_	3	det	_
3	deal	deal	NN	_	1	pobj	_
4	,	,	,	_	8	punct	_
5	Pfizer	pfizer	NNP	p2=NN	8	nsubj	8:A1=PPT
6	would	would	MD	_	8	aux	8:AM-MOD
7	then	then	RB	_	8	advmod	8:AM-TMP
8	be	be	VB	pb=be.01	0	root	_
9	the	the	DT	_	10	det	_
10	buyer	buyer	NN	_	8	attr	8:A2=PRD
11	in	in	IN	_	10	prep	_
12	four	#crd#	CD	_	11	pobj	_
13	of	of	IN	_	12	prep	_
14	the	the	DT	_	17	det	_
15	10	0	CD	_	17	num	_
16	richest	rich	JJS	_	17	amod	_
17	deals	deal	NNS	_	13	pobj	_
18	ever	ever	RB	_	17	advmod	_
19	in	in	IN	_	17	prep	_
20	the	the	DT	_	22	det	_
21	pharmaceutical	pharmaceutical	JJ	_	22	amod	_
22	industry	industry	NN	_	19	pobj	_
23	.	.	.	_	8	punct	_

1	Each	each	DT	_	5	nsubj	5:A1=PPT
2	of	of	IN	_	1	prep	_
3	those	those	DT	_	4	det	_
4	deals	deal	NNS	_	2	pobj	_
5	resulted	result	VBD	p2=VBN|pb=result.01	0	root	_
6	in	in	IN	_	5	prep	5:A2=LOC
7	massive	massive	JJ	_	8	amod	_
8	layoffs	layoff	NNS	_	6	pobj	_
9	and	and	CC	_	8	cc	_
10	closures	closure	NNS	_	8	conj	_
11	of	of	IN	_	8	prep	_
12	some	some	DT	_	14	det	_
13	medicine	medicine	NN	p2=JJ	14	nn	_
14	factories	factory	NNS	_	11	pobj	_
15	,	,	,	_	14	punct	_
16	research	research	NN	_	17	nn	_
17	facilities	facility	NNS	_	14	conj	_
18	and	and	CC	_	17	cc	_
19	office	office	NN	_	20	nn	_
20	buildings	building	NNS	_	17	conj	_
21	,	,	,	_	17	punct	_
22	with	with	IN	_	17	prep	_
23	the	the	DT	_	26	det	_
24	cost	cost	NN	_	26	hmod	_
25	-	-	HYPH	p2=,	26	hyph	_
26	cutting	cutting	NN	p2=VBG	27	nsubj	27:A0=PAG
27	boosting	boost	VBG	pb=boost.01	22	pcomp	_
28	Pfizer	pfizer	NNP	p2=NN	31	poss	_
29	's	's	POS	_	28	possessive	_
30	bottom	bottom	JJ	p2=NN	31	amod	_
31	line	line	NN	_	27	dobj	27:A1=PPT
32	for	for	IN	_	31	prep	_
33	a	a	DT	_	35	det	_
34	few	few	JJ	_	35	amod	_
35	years	year	NNS	_	32	pobj	_
36	.	.	.	_	5	punct	_

1	That	that	DT	_	2	nsubj	2:A1=PPT
2	's	be	VBZ	pb=be.01	0	root	_
3	clearly	clearly	RB	_	2	advmod	2:AM-ADV
4	a	a	DT	_	6	det	_
5	key	key	JJ	_	6	amod	_
6	part	part	NN	_	2	attr	2:A2=PRD
7	of	of	IN	_	6	prep	_
8	the	the	DT	_	9	det	_
9	rationale	rationale	NN	_	7	pobj	_
10	for	for	IN	_	9	prep	_
11	this	this	DT	_	12	det	_
12	proposal	proposal	NN	_	10	pobj	_
13	,	,	,	_	2	punct	_
14	along	along	IN	_	2	prep	_
15	with	with	IN	_	14	prep	_
16	the	the	DT	_	17	det	_
17	prospect	prospect	NN	_	15	pobj	_
18	of	of	IN	_	17	prep	_
19	lower	low	JJR	_	20	amod	_
20	taxes	tax	NNS	_	18	pobj	_
21	and	and	CC	_	20	cc	_
22	getting	get	VBG	pb=get.01	20	conj	_
23	some	some	DT	_	26	det	_
24	promising	promise	VBG	p2=JJ|pb=promise.01	26	amod	_
25	experimental	experimental	JJ	_	26	amod	_
26	drugs	drug	NNS	_	22	dobj	24:A0=PAG;22:A1=PPT
27	from	from	IN	_	22	prep	22:A2=DIR
28	AstraZeneca	astrazeneca	NNP	_	30	poss	_
29	's	's	POS	_	28	possessive	_
30	labs	lab	NNS	_	27	pobj	_
31	.	.	.	_	2	punct	_

1	Pfizer	pfizer	NNP	_	3	nsubj	3:A0=PAG;5:A0=PAG;11:A0=PAG
2	also	also	RB	_	3	advmod	3:AM-DIS
3	wants	want	VBZ	pb=want.01	0	root	_
4	to	to	TO	_	5	aux	_
5	add	add	VB	pb=add.02	3	xcomp	3:A1=PPT
6	to	to	IN	_	5	prep	5:A2=PPT
7	its	its	PRP$	_	9	poss	_
8	medicine	medicine	NN	_	9	nn	_
9	portfolio	portfolio	NN	_	6	pobj	_
10	to	to	TO	_	11	aux	_
11	boost	boost	VB	pb=boost.01	5	advcl	5:AM-PRP
12	revenue	revenue	NN	_	11	dobj	11:A1=PPT
13	.	.	.	_	3	punct	_

1	The	the	DT	_	2	det	_
2	company	company	NN	_	3	nsubj	3:A1=PPT
3	slipped	slip	VBD	pb=slip.01	0	root	_
4	from	from	IN	_	3	prep	3:A3=DIR
5	No.	no.	NN	_	4	pobj	_
6	1	0	CD	_	5	num	_
7	to	to	IN	_	3	prep	3:A4=GOL
8	No.	no.	NN	_	7	pobj	_
9	2	0	CD	_	8	num	_
10	last	last	JJ	_	11	amod	_
11	year	year	NN	_	3	npadvmod	3:AM-TMP
12	,	,	,	_	3	punct	_
13	behind	behind	IN	_	3	prep	_
14	Novartis	novartis	NNP	_	15	nn	_
15	AG	ag	NNP	_	13	pobj	_
16	,	,	,	_	3	punct	_
17	mainly	mainly	RB	_	20	advmod	_
18	because	because	IN	_	20	mark	_
19	Lipitor	lipitor	NNP	p2=NN	20	nsubj	20:A0=PAG;29:A0=PAG
20	got	get	VBD	pb=get.01	3	advcl	_
21	generic	generic	JJ	_	22	amod	_
22	competition	competition	NN	_	20	dobj	20:A1=PPT
23	at	at	IN	_	20	prep	20:AM-TMP
24	the	the	DT	_	25	det	_
25	end	end	NN	_	23	pobj	_
26	of	of	IN	_	25	prep	_
27	2011	0	CD	_	26	pobj	_
28	,	,	,	_	20	punct	_
29	wiping	wipe	VBG	pb=wipe.02	20	advcl	20:AM-ADV
30	out	out	RP	_	29	prt	29:C-V
31	several	several	JJ	_	32	amod	_
32	billion	#crd#	CD	_	33	num	_
33	dollars	dollar	NNS	_	29	dobj	29:A1=PPT
34	in	in	IN	_	29	prep	_
35	annual	annual	JJ	_	36	amod	_
36	sales	sale	NNS	_	34	pobj	_
37	.	.	.	_	3	punct	_

1	Pfizer	pfizer	NNP	p2=NN	4	nsubj	4:A0=PAG;13:A1
2	also	also	RB	_	4	advmod	4:AM-DIS
3	has	have	VBZ	_	4	aux	_
4	sold	sell	VBN	pb=sell.01	32	ccomp	_
5	off	off	RP	_	4	prt	4:C-V
6	a	a	DT	_	8	det	_
7	couple	couple	NN	p2=JJ	8	nn	_
8	parts	part	NNS	_	4	dobj	4:A1=PPT
9	of	of	IN	_	8	prep	_
10	its	its	PRP$	_	11	poss	_
11	business	business	NN	_	9	pobj	_
12	and	and	CC	_	4	cc	_
13	reorganized	reorganize	VBN	p2=VBD|pb=reorganize.01	4	conj	_
14	as	as	IN	_	13	prep	_
15	part	part	NN	_	14	pobj	_
16	of	of	IN	_	15	prep	_
17	preparations	preparation	NNS	_	16	pobj	_
18	to	to	TO	_	20	aux	_
19	possibly	possibly	RB	_	20	advmod	20:AM-ADV
20	break	break	VB	pb=break.01	13	advcl	13:AM-PRP
21	off	off	RP	_	20	prt	20:C-V
22	another	another	DT	_	23	det	_
23	part	part	NN	_	20	dobj	20:A1=PPT
24	of	of	IN	_	23	prep	_
25	the	the	DT	_	26	det	_
26	company	company	NN	_	24	pobj	_
27	,	,	,	_	32	punct	_
28	something	something	NN	_	29	nn	_
29	analysts	analyst	NNS	_	32	nsubj	32:A0=PAG
30	have	have	VBP	_	32	aux	_
31	been	be	VBN	_	32	aux	_
32	urging	urge	VBG	pb=urge.01	0	root	_
33	it	it	PRP	_	32	dobj	35:A0=PAG;32:A1=PPT
34	to	to	TO	_	35	aux	_
35	do	do	VB	pb=do.02	32	xcomp	32:A2=PPT
36	.	.	.	_	32	punct	_

1	©	©	$	p2=SYM	2	quantmod	_
2	2014	0	CD	_	4	num	_
3	Sun-Times	sun-times	NNP	p2=NNPS	4	nn	_
4	Media	media	NNP	_	0	root	_
5	,	,	,	_	4	punct	_
6	LLC	llc	NNP	_	4	appos	_
7	.	.	.	_	2	punct	_

1	All	all	DT	_	2	det	_
2	rights	right	NNS	_	3	nsubj	3:A1=PPT
3	reserved	reserve	VBN	p2=VBD|pb=reserve.01	0	root	_
4	.	.	.	_	3	punct	_

1	This	this	DT	_	2	det	_
2	material	material	NN	_	6	nsubjpass	6:A1=PPT;8:A1=PPT
3	may	may	MD	_	6	aux	6:AM-MOD;8:AM-MOD
4	not	not	RB	_	6	neg	6:AM-NEG;8:AM-NEG
5	be	be	VB	_	6	auxpass	_
6	copied	copy	VBN	pb=copy.01	0	root	_
7	or	or	CC	_	6	cc	_
8	distributed	distribute	VBN	pb=distribute.01	6	conj	_
9	without	without	IN	_	8	prep	8:AM-MNR
10	permission	permission	NN	_	9	pobj	_
11	.	.	.	_	6	punct	_

1	For	for	IN	_	9	prep	9:AM-PRP
2	more	more	JJR	_	3	amod	_
3	information	information	NN	_	1	pobj	_
4	about	about	IN	_	3	prep	_
5	reprints	reprint	NNS	p2=NN	4	pobj	_
6	and	and	CC	_	5	cc	_
7	permissions	permission	NNS	_	5	conj	_
8	,	,	,	_	9	punct	_
9	visit	visit	VB	pb=visit.01	0	root	_
10	www.suntimesreprints.com	#url#	ADD	_	9	dobj	9:A1=COM
11	.	.	.	_	9	punct	_

1	To	to	TO	_	2	aux	_
2	order	order	VB	pb=order.01	9	advcl	9:AM-PRP
3	a	a	DT	_	4	det	_
4	reprint	reprint	NN	_	2	dobj	2:A1=GOL
5	of	of	IN	_	4	prep	_
6	this	this	DT	_	7	det	_
7	article	article	NN	_	5	pobj	_
8	,	,	,	_	9	punct	_
9	click	click	VB	pb=click.01	0	root	_
10	here	here	RB	_	9	advmod	9:AM-LOC
11	.	.	.	_	9	punct	_

